Coeptis Therapeutics  Inc. logo

Coeptis Therapeutics Inc.

COEP | NASDAQ
Chart Builder DCF Calculator
$10.99
-$1.03 (-8.57%)
At close: Jul 2, 2026, 3:59 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Cash & Equivalents
5.67M 532.89K 1.47M 3.79M 2.18M 202.97K
Short-Term Investments
676.6K n/a n/a n/a n/a n/a
Long-Term Investments
7.86M 5.69M 3.5M n/a n/a n/a
Other Long-Term Assets
4.25M 1.56M 158.33K 348.33K 4.55M 2K
Receivables
7.35K n/a 38.98K 8.08K n/a 21.79K
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a n/a n/a
Total Current Assets
7.35M 1.05M 1.75M 3.94M 2.18M 224.75K
Property-Plant & Equipment
18.4K 59.78K 108.88K 71.46K 31.85K 73.73K
Goodwill & Intangibles
361.25K 541.88K 2.55M 3.55M 4.55M n/a
Total Long-Term Assets
12.49M 7.86M 6.32M 3.97M 4.59M 75.73K
Total Assets
19.84M 8.91M 8.07M 7.92M 6.77M 300.48K
Account Payables
888.76K 1.27M 1.42M 99.02K 134.09K 1.62M
Deferred Revenue
599.46K n/a n/a n/a n/a 1M
Short-Term Debt
118.88K 1.19M 1.01M 1.89M 2.42M 1.88M
Other Current Liabilities
161.05K 1.28M 555.95K 182K 199.13K n/a
Total Current Liabilities
1.77M 4.51M 2.99M 2.17M 2.76M 5.28M
Long-Term Debt
150K 150K 150K 150K 1.65M 150K
Other Long-Term Liabilities
167.63K 359.25K 557.25K 1.13M n/a -1
Total Long-Term Liabilities
317.63K 528.13K 768.43K 1.29M 1.65M 164.72K
Total Liabilities
2.09M 5.04M 3.76M 3.46M 4.41M 5.44M
Total Debt
268.88K 1.4M 1.22M 2.06M 4.08M 2.09M
Book Value
17.75M 3.87M 4.31M 4.45M 2.35M -5.14M
Book Value Per Share
4.19 2.01 0.17 0.31 2.30 -0.25
Common Stock
575 212 3.53K 1.96K 3.55K 2.52K
Retained Earnings
-109.95M -98.23M -87.36M -66.09M -27.55M -14.1M
Comprehensive Income
n/a n/a n/a n/a n/a n/a
Shareholders Equity
17.25M 3.19M 4.31M 4.45M 2.35M -5.14M
Total Investments
8.54M 5.69M 3.5M n/a n/a n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.